Top 7 Pharma Industry Leaders in 2020 By the Numbers
Delveinsight
AUGUST 25, 2021
MAVYRET (Glecaprevir and pibrentasvir) (for Chronic HCV genotype), Skyrizi (Risankizumab) (for plaque psoriasis), and VENCLEXTA (Venetoclax) (for Chronic lymphocytic leukemia, and Acute Myeloid Leukemia) generated nearly same amount of revenue share i.e. 0.3% (USD 1.8 Imbruvica contributed USD 5.3 billion , around 11.5% of revenue share.
98 
Let's personalize your content